News

 
Following are announcements of notable deals and cases on which Davis Polk has advised, as well as a range of other news items about the firm and our lawyers. 
February 21, 2021 Davis Polk welcomes Capital Markets partner Jason Xu in Beijing
February 19, 2021 InnoCare Pharma HK$3.04 billion share placement
We advised InnoCare Pharma in the placement of new shares
February 18, 2021 New Horizon Health HK$2.04 billion IPO
We advised New Horizon Health on its IPO and HKEX listing
February 17, 2021 Martin Rogers named among Asia’s top 15 litigators by Asian Legal Business
February 17, 2021 Youdao $238 million equity follow-on offering
We advised Youdao on its offering of ADSs
February 17, 2021 Akeso HK$1.19 billion share placement
We advised the placing agent in the placement of new shares
February 12, 2021 Davis Polk shortlisted for three IFLR Asia-Pacific 2021 awards
February 11, 2021 Adagene $161 million IPO
We advised Adagene on its IPO and Nasdaq listing
February 4, 2021 Six Davis Polk deals selected as China Business Law Journal 2020 “Deals of the Year”
January 25, 2021 Innovent Biologics HK$4.73 billion placement of shares
We advised the joint placing agents in connection with the equity offering

News

News Search: